<ul><li>Clock.bio, a healthspan biotechnology company, has raised $5.3M in seed funding to advance its research on human rejuvenation.</li><li>The company uses human induced pluripotent stem cells (iPSCs) to study the natural rejuvenation mechanisms.</li><li>Over 100 genes that play a crucial role in the rejuvenation process have been identified.</li><li>Clock.bio aims to develop novel treatments for age-related diseases and increase human healthspan.</li></ul>

clock.bio Raises $5.3M to Decode Human Rejuvenation, Develop Anti-Aging Therapies

Discover more